Urge Congress to Support the Creation of an FDA Neuroscience Center of Excellence

Leaders of the Congressional Neuroscience Caucus and the Brain Injury Task Force are circulating a sign-on letter to the Energy and Commerce Committee, in support of the creation of an NCOE at the FDA.

Leaders of the Congressional Neuroscience Caucus and the Brain Injury Task Force are circulating a sign-on letter to the Energy and Commerce Committee, in support of the creation of an NCOE at the FDA

The Cures 2.0 Act, recently introduced by Congresswoman Diana DeGette and Congressman Fred Upton, includes language that would pave the way for the creation of an NCOE at the FDA. This language complements the Bringing Regulatory Advances Into Neuroscience (BRAIN) Act, advanced by Congressman Earl Blumenauer, Congressman Bill Pascrell, and Congressman Don Bacon, which would direct the FDA to create an NCOE.

We call on you to urge your member of Congress to advance scientific research on brain trauma and brain health by co-sponsoring the BRAIN Act and signing the NCOE Dear Colleague letter today.

Thank you for taking action for brain health!

Send an ACTION ALERT today, it’s easy and will only take a minute!

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/cv.webp

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

https://www.cohenveteransbioscience.org/wp-content/uploads/2022/11/bigstock-Dna-With-Unique-Connection-155670029.jpg

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/03/what-is-post-traumatic-stress-disorder-ptsd-scaled.jpeg

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.